Patent · US Active

Anti-c-Met antibody drug conjugates

US11633497B2 · kind B2 · utility

0Cited by
14References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 29, 2022
Grant dateApr 25, 2023
Priority date—
Expiry dateApr 29, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.